National Health Investors, Inc. (NHI) Rating Lowered to Hold at Zacks Investment Research
National Health Investors, Inc. (NYSE:NHI) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Wednesday.
According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “
NHI has been the topic of several other reports. BidaskClub upgraded National Health Investors from a “sell” rating to a “hold” rating in a research report on Thursday, August 17th. Mizuho reiterated a “neutral” rating on shares of National Health Investors in a research report on Wednesday, June 28th. Stifel Nicolaus increased their price objective on National Health Investors from $80.00 to $82.00 and gave the company a “buy” rating in a research report on Wednesday, June 21st. ValuEngine lowered National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, June 13th. Finally, Bank of America Corporation lowered National Health Investors from a “neutral” rating to an “underperform” rating and set a $76.00 price objective on the stock. in a research report on Monday, May 22nd. One analyst has rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $81.40.
National Health Investors (NHI) traded up 0.20% on Wednesday, reaching $80.59. The company’s stock had a trading volume of 149,229 shares. The stock’s 50 day moving average price is $78.14 and its 200 day moving average price is $75.77. National Health Investors has a 52-week low of $66.31 and a 52-week high of $81.29. The firm has a market cap of $3.30 billion, a PE ratio of 20.70 and a beta of 0.56.
National Health Investors (NYSE:NHI) last announced its earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share for the quarter, missing analysts’ consensus estimates of $1.29 by $0.36. The business had revenue of $69.84 million during the quarter, compared to the consensus estimate of $67.68 million. National Health Investors had a return on equity of 12.56% and a net margin of 59.24%. National Health Investors’s revenue was up 14.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.22 earnings per share. Equities research analysts expect that National Health Investors will post $3.85 earnings per share for the current fiscal year.
In other news, insider Kevin Carlton Pascoe sold 2,000 shares of the stock in a transaction dated Thursday, August 24th. The stock was sold at an average price of $79.80, for a total transaction of $159,600.00. Following the transaction, the insider now directly owns 21,228 shares in the company, valued at approximately $1,693,994.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 5.19% of the stock is currently owned by corporate insiders.
Institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. grew its position in National Health Investors by 1.2% during the 2nd quarter. Vanguard Group Inc. now owns 6,291,954 shares of the real estate investment trust’s stock worth $498,323,000 after acquiring an additional 72,518 shares during the last quarter. BlackRock Inc. grew its position in National Health Investors by 6.6% during the 2nd quarter. BlackRock Inc. now owns 3,547,049 shares of the real estate investment trust’s stock worth $280,927,000 after acquiring an additional 218,482 shares during the last quarter. Northern Trust Corp grew its position in National Health Investors by 6.4% during the 2nd quarter. Northern Trust Corp now owns 1,007,869 shares of the real estate investment trust’s stock worth $79,823,000 after acquiring an additional 60,784 shares during the last quarter. State Street Corp grew its position in National Health Investors by 8.5% during the 2nd quarter. State Street Corp now owns 999,167 shares of the real estate investment trust’s stock worth $79,133,000 after acquiring an additional 78,355 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its position in National Health Investors by 4.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 565,542 shares of the real estate investment trust’s stock worth $44,790,000 after acquiring an additional 22,697 shares during the last quarter. Hedge funds and other institutional investors own 70.58% of the company’s stock.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.